The ureteral obstruction (UO) is the most common clinical disorders. This study was designed to investigate the renoprotective effect of estradiol in unilateral UO (UUO) and reversible UUO (RUUO).
Introduction
Ureteral obstruction (UO) is one of the most clinical disorder in the progression of renal dysfunction.(1,2) UO reduces the glomerular filtration rate (GFR) that leads to natriuresis, sodium and water excretion disturbances. (3) In order to restore the kidney function after unilateral UO (UUO), the obstruction must be removed either by drug or surgery. The surgery itself may accompany with alteration of renal medullary plasma flow and fluid reabsorption.(4) The UUO induced inflammation and tissue damage are resulted from stress oxidative formation. (5) The antioxidants supplementation is one of best and well documented treatment to decrease the stress oxidative. In addition, the female sex hormone estrogen has been known as an endogenous antioxidant that its protective role in cardiovascular system has been accepted in women before menopause. The protective role of this hormone against chronic kidney disease also was reported (6) , and the protection mechanism may related to glomerulosclerosis and interstitial tubular fibrosis prevention (7) . Mao, et al., performed UUO in rats after 3 weeks of estradiol treatment (as prophylaxis), and the GFR and kidney tissue damage were evaluated about two weeks later, and they concluded that estradiol affected renal function in UUO model. (8) However, the short time effect of estradiol in UUO and after UUO removal (reversible UUO, RUUO) need to be studied. Based on epidemiological study that estrogen therapy improves GFR and blood pressure in postmenopausal women (9) , there is hypothesized that estradiol could protect the kidney function against UUO and RUUO. To test this hypothesis, renal function makers were assessed in UUO and RUUO in ovariectomized estradiol treated rats.
Methods
This study was performed on 84 ovariectiomized female (180±20 g) Wistar rats, and it was approved in advance by the 
Ovariectomy
The animals were anesthetized with chloral hydrate (450 mg/kg) (Merck, Darmstadt, Germany). The incision was Table 1 . The summary of study design.
performed in suprapubic region, and the ovaries were removed with care. The ovariectomized animals were kept in animal cages for one week as a recovery period.
To collect urine from manipulated kidney, at the sacrifice day the right kidney was removed (nephrectomy), and after the recovery time, the animals were placed in standard metabolic cages for 6 hours to collect the urine for the measurements. Finally, the animals were sacrificed humanly with anesthetic drug, and the kidney and uterus were removed and weighted rapidly.
UUO and RUUO
After recovery period, the rats were anesthetized again, and the incision was made on the abdominal skin, the left kidneys were pulled out gently and the ureter was isolated from other surrounding tissues while the right kidney remained intact. The ureter was obstructed with 3-0 nylon suture. The kidneys were returned back to abdominal cavity. In order to perform RUUO model, the animals were anesthetized again 3 days after UUO, left kidney and obstructed ureter were exposed and the tie around the ureter was released carefully.
Experimental Groups
The experimental groups were assigned as following: 1) Group 1 (sham operated) was subjected to surgical procedure without UUO and sacrificed 3 days 
Results

Body weight Changes
The alteration of body weight (BW) during the experiment is shown in Figure 1 . The upper panel shows the percentage (%) change of BW in the animals subjected to UUO treated with vehicle or estradiol and compared with sham group. later; 2) Group 2-4 were subjected to UUO and received vehicle, 0.1 mg/kg of estradiol, or 0.5 mg/kg of estradiol respectively, and sacrificed 3 days later; 3) Group 5-7 were subjected to UUO and received vehicle, 0.1 mg/kg of estradiol, or 0.5 mg/kg of estradiol respectively, but 3 days later, the obstruction was removed (named RUUO), and the animals were sacrificed one day post RUUO; 4) Group 8 and 9 were treated as group 6 and 7 except they received estradiol (0.1 or 0.5 mg/kg) after RUUO and sacrificed one day post RUUO; 5) Group 10-12 were subjected to UUO, and 3 days later the obstruction was removed and the animals were treated with vehicle, 0.1 mg/kg estradiol, or 0.5 mg/kg of estradiol respectively and sacrificed 3 days post RUUO; and 6) Group 13 and 14 were treated as group 11 and 12 except that they received estradiol both at the day of UUO and at the day of RUUO. The summary of groups design is shown in Table 1 .
Blood Samples and Measurements
Blood samples were taken via heart puncture after urine collection and stored in -20 o C. The levels of urine and serum creatinine (Cr) and blood urea nitrogen (BUN) were determined using quantitative diagnostic kits (Pars Azmoon, Tehran, Iran) and automatic analyzer RA-1000 (Technicon, Dublin, Ireland). Urine and plasma sodium (Na) concentrations were measured by phlamephotomer assay. The Cr clearance (CrCl), urine Na excretion (UNaV) and urine flow (UF) also were determined. After sacrificing, the left kidney and uterus were removed carefully and the kidney weight (KW) and uterus weight (UW) were determined using digital scale. The KW and UW were normalized based on 100 g of body weight.
Statistical Analyses
The data were reported as mean±standard error of mean (SE). The ANOVA for repeated measures was applied to analyses the body weight change between the groups. One way ANOVA and Tukey as a post hoc test were employed to compare the kidney function markers between the groups. The p-value less than 0.05 was considered as significant.
The % change of BW in sham group was significantly different from estradiol treated groups (p<0.05). No significant differences between the groups were seen in the middle and lower panels indicated that estradiol treatment did not alter BW changes.
The Effect of Estradiol on UUO
The UUO alone increased the serum levels of BUN and Cr, and kidney weight (KW) significantly (p<0.05). The ovaries were removed by ovariectomy, however the estradiol increased the UW statistically (p<0.05) as expected, but it did not alter the serum level of BUN and Cr, and KW when compared with control group (Figure 2) . No urine was collected in this situation.
The Effect of Estradiol in RUUO Models
The 3 days of UUO followed by 24 hours of RUUO in rats treated with different estradiol dosages did not alter the levels of BUN, Cr, CrCl, UF, UNaV and KW when compared with control group (Figure 3, left panel) . In addition, the 3 days of UUO followed by 3 days of RUUO in rats treated with different estradiol dosages also did not alter the mentioned markers ( Figure 3, right panel) . However, the UW increased significantly in all estradiol treated groups as expected (p<0.05) (Figure 3 ).
Discussion
The adverse effect of UUO even after RUUO is a serious problem in clinic, and special care is needed to least the adverse side effects during or after RUUO. Estrogen as an antioxidant and cardiovascular protectant agent in female always has been nominated. The current study was designed to evaluate the effect of estradiol on renal function markers in conditions of UUO and RUUO in rats. The estradiol was administered at the time of obstruction, after RUUO or both, and the kidney functions markers were evaluated. It seems that the protective role of estradiol in renal system was not certain.
Previously, it is reported that UUO is accompanied with increasing of serum BUN and Cr levels (10), reduction of GFR about 20-70% (11, 12) , decreasing of tubular injury and interstitial fibrosis (13) , reduction of UNaV and urine osmolality (14) , and increasing of fibronectin expression (15) . In our study, the serum level of BUN and Cr were increased by UUO possibly by renal fibrosis or GFR reduction. We did not measure the CrCl in UUO alone groups due to lack of urine flow. It seems this disturbance The p values were obtained by one way ANOVA, and the symbols of (*) and (#) showed significant difference from sham and control groups respectively (p<0.05) using Tukey as post hoc test. Figure 3 . The serum levels of blood urea nitrogen (BUN), creatinine (Cr), kidney weight (Kw)/ 100 g body weight (Bw) and ureter weight/100 g Bw (Uw) in control groups (group 5 and 10) and estradiol treated groups which received 0.1 mg/kg (Es0.1) or 0.5 mg/kg (Es0.5) of estradiol (groups 6-9 and groups 11-14) (n = 6 in each group). All the groups were subjected to unilateral ureteral obstruction (UUO) for three day, and the obstruction was removed (called unilateral ureteral obstruction removal, RUUO) for 24 hours or 3 days. The p values were obtained by one way ANOVA, and the symbols of (*) or ( †) show significant difference from control or adjacent group (p<0.05) using Tukey as post hoc test.
decreased GFR and accumulated Cr or BUN in the body.
Renal fibrosis due to UUO also causes damage to the kidney's main cells, which results decreasing of GFR and tubular reabsorption, and increasing of serum Cr levels.(16) Renin angiotensin system (RAS) also is another system that is disturbed by UUO. (17, 18) The RAS plays a great role in the adjustment of the hemodynamics in UUO model (19) , and it has also been shown that after UUO, the local production of angiotensin II increased (20) which may result low renal blood flow (RBF) and GFR.
Estradiol is usually thought to be renoprotective. It is anti-apoptosis (21) and anti-inflammation (22, 23) . In our model, the estradiol did not demonstrate an effective role on kidney functions markers. One possibility is related to estradiol treatment duration, because it is reported that estradiol had no effect on the serum levels of BUN and Cr, and CrCl in UO model on day 2 and 6, but on day 16 the protective effect of estradiol on renal function was detected. (8) However, in this study we used different doses of estradiol to determine the short time effect of estradiol, and estradiol treated groups which received 0.1 mg/kg (Es0.1) or 0.5 mg/kg (Es0.5) of estradiol (groups 6-9 and groups 11-14) (n = 6 in each group). All the groups were subjected to unilateral ureteral obstruction (UUO) for three day, and then obstruction was removed (called unilateral ureteral obstruction removal, RUUO) for 24 hours or 3 days. A one way ANOVA test shows no significant differences were detected between the groups. because the estradiol effect may depend on treatment time and dosage. Our findings also did not demonstrate any considerable protective action of estradiol after RUUO. The RUUO eliminated the initial stimulus, but the interstitial damage may be remained. Chevalier, et al., reported that initial urinary tract injury was remained 1 month after the surgery. (24) Other study indicated that improving of the tubular function in obstructive kidney needs to more than 2 weeks after the RUUO. (25) Hasanshahi and Nematbakhsh reported that 3-days UUO decreased RBF and increased renal vascular resistances (RVR) in ipsilatral kidney. (26) It is also reported the significant increase of GFR at 72 hours after RUUO, while no change in UNaV shortly after RUUO was observed. (27) In a preliminary report founded that three months after 5-days of UUO in the neonatal rat, the GFR of the post obstructed kidney was reduced by 50% (28) . Some of these findings were similar to our study; however our data did not confirm the protective effect of estradiol after RUUO possibly due to non-chronic treatment of estradiol.
Conclusion
Although estradiol is a well-known protective agent in cardiovascular system, however our findings suggest that the short time effect of different doses of estradiol on UUO or on RUUO models is not certain, and its protective effect may occur long time after RUUO while short-term injury induced by UUO progress even after RUUO.
